Next Gen Diagnostics Announces Opening of a US Sequencing and Bioinformatics Laboratory in Cambridge, Massachusetts

Next Gen Diagnostics announces its first US laboratory will be opening in Cambridge, Massachusetts to provide low cost fully integrated bacterial sequencing and bioinformatics to US customers and partners.  Leveraging the advantages of its NGD100 high throughput microfluidic sequencing sample preparation instrument and automated pathogen bioinformatics systems, NGD offers sequencing combined with complete bioinformatics results at the lowest cost in the United States.   Along with low sequencing cost, users get access to NGD’s user interface, providing both an information-rich transmission detection application designed for infection control teams as well as powerful antibiotic resistance analysis and visualization tools to explore the interplay of cohort phylogeny, genomic resistance elements, and phenotype, a tool to advance understanding of the mechanisms of antibiotic resistance.